Virpax Pharmaceuticals, Inc. (VRPX)
OTCMKTS · Delayed Price · Currency is USD
0.0110
0.00 (0.00%)
Feb 4, 2026, 4:00 PM EST
Virpax Pharmaceuticals Employees
Virpax Pharmaceuticals had 2 employees as of December 31, 2024. The number of employees decreased by 5 or -71.43% compared to the previous year.
Employees
2
Change (1Y)
-5
Growth (1Y)
-71.43%
Revenue / Employee
n/a
Profits / Employee
-$6,033,613
Market Cap
13.79K
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 2 | -5 | -71.43% | 2 | 0 |
| Dec 31, 2023 | 7 | 0 | - | 7 | 0 |
| Dec 31, 2022 | 7 | 0 | - | 7 | 0 |
| Dec 31, 2021 | 7 | 5 | 250.00% | 7 | 0 |
| Jun 30, 2021 | 7 | 5 | 250.00% | 6 | 1 |
| Dec 31, 2020 | 2 | 0 | - | 2 | 0 |
| Sep 30, 2020 | 2 | 0 | - | 2 | 0 |
| Jun 30, 2020 | 2 | - | - | 2 | 0 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Virpax Pharmaceuticals News
- 11 months ago - Virpax Pharmaceuticals to conduct reverse stock split - Seeking Alpha
- 11 months ago - Virpax Pharmaceuticals Announces Reverse Stock Split - Business Wire
- 11 months ago - Virpax Receives Positive Probudur™ Results for Dose Range Study Moves Towards Next Steps in IND - Business Wire
- 1 year ago - Virpax Looking to Use MET to Develop Intranasal COVID Vaccine - Business Wire
- 1 year ago - Virpax's NES100 to be Presented at The Society of Toxicology by NCATS - Business Wire
- 1 year ago - Virpax Reports Positive Results in Human Study for its Molecular Envelope Technology - Business Wire
- 1 year ago - Penny Stock Virpax Pharmaceuticals Surges On US Army-Performed Preclinical Study For Pain Candidate - Benzinga
- 1 year ago - Virpax Confirms Positive Results with US Army with Probudur™ for Combat Care Study - Business Wire